These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 24518219)
1. RAD18 mediates resistance to ionizing radiation in human glioma cells. Xie C; Wang H; Cheng H; Li J; Wang Z; Yue W Biochem Biophys Res Commun; 2014 Feb; 445(1):263-8. PubMed ID: 24518219 [TBL] [Abstract][Full Text] [Related]
2. High expression of RAD18 in glioma induces radiotherapy resistance via down-regulating P53 expression. Wu B; Wang H; Zhang L; Sun C; Li H; Jiang C; Liu X Biomed Pharmacother; 2019 Apr; 112():108555. PubMed ID: 30798132 [TBL] [Abstract][Full Text] [Related]
3. RAD18 activates the G2/M checkpoint through DNA damage signaling to maintain genome integrity after ionizing radiation exposure. Sasatani M; Xu Y; Kawai H; Cao L; Tateishi S; Shimura T; Li J; Iizuka D; Noda A; Hamasaki K; Kusunoki Y; Kamiya K PLoS One; 2015; 10(2):e0117845. PubMed ID: 25675240 [TBL] [Abstract][Full Text] [Related]
4. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties. Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of LGMNP1 confers radiotherapy resistance in glioblastoma. Xu H; Chen B; Xing J; Wei Z; Liu C; Qiu Y; Lin Y; Ren L Oncol Rep; 2019 Jun; 41(6):3435-3443. PubMed ID: 31002346 [TBL] [Abstract][Full Text] [Related]
6. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination. Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278 [TBL] [Abstract][Full Text] [Related]
7. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma. Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483 [TBL] [Abstract][Full Text] [Related]